Alpha Tau Medical

Monday.   6:00 AM.   Thirty highly energized Alpha Tau Medical employees board a bus heading north.   For the rest of the day, they work to help the people of Metula clean up debris and slowly pick up the literal pieces of where life left off last October. Amid the bombed houses, a stillness pervades.   “Metula feels like something out of an old Western. Shattered glass and broken homes. But this shell-shocked town is slowly coming back to life. The spirit has not been broken. We came to help physically, but our endeavor to bring our spirit to the work was what was most appreciated,” said one of the #volunteers on the trip, which was organized by the Lev Echad (One Heart) organization.   The team got home late that night, tired but proud to have been able to contribute its small part.

Alpha Tau Medical capped off the final night of Hanukkah with a beautiful company event in Jerusalem. We lit the last candle together, saluted our over 30 colleagues who have been in active #militaryservice, and crowned the outstanding #employees of 2024: Gili Matias (IT), Rebecca (Feldman) Becker (VP Legal), Lauren Benhamou (Marketing), Shahar Polak (R&D), Aurelie Azoulay🎗(Q&A), Yair Zecharya (R&D) and Tzufit Cukier (CTA). A lovely and hopeful note on which to start 2025...

"I always dreamed of being a doctor. My mom says I used to give check-ups to all my dolls as a child. Even today, when I’m not reading for pleasure, I spend my free time reading articles about cancer and diseases. After getting married and having six kids, I realized I was giving up on that dream, but I’m still grateful to be working my entire life in a field I love."   Aviya Hoida, a CTA (Clinical Trial Assistant) at Alpha Tau Medical, grew up in Petah Tikva and now lives in Mevo Horon with her husband and six children (aged 3-18).   She holds an extended degree in #biology from Bar-Ilan University and previously taught science in school before making a career change to become a CRA (Clinical Research Associate). For 15 years, she worked directly with patients at Shaare Zedek Medical Center, first in the hematology-oncology division and later as a clinical coordinator in the gastroenterology department, specifically in the unit for inflammatory bowel diseases in pregnant women (IBD MOM). Her next stop was Alpha Tau Medical.   “I was interested in technology and wanted to help people. I knew I had a lot of knowledge and experience in #oncology, and I wanted to use it. I felt that this was a company that had made a breakthrough in its field, and it was an opportunity for me to diversify and do something meaningful.”   As a CTA at Alpha Tau, she is responsible for submitting new research studies to the medical sites we partner with to perform #clinicaltrials, maintaining ongoing communication with the sites, and liaising with the study’s central laboratory.   In her free time, Aviya works out at the gym (three times a week!) and never stops reading. She’s currently reading “Speaking with the Messiah Now” by Rabbi Shmuel Raskin and “Pnima” magazine.

The radiotherapeutics market is one of the fastest-growing markets in cancer treatment today. Alpha Tau Medical is aiming for a unique position within this market: our intra-tumoral approach, currently available only in #clinicaltrials, is designed to target just the #cancer without harming healthy surrounding tissue.   Join the ride with the rising force making waves in the industry. Come see what we’re all about at the J.P. Morgan #HealthcareConference in #SanFrancisco (January 13-16). #JPM2025    

Happy holidays to all our friends!   For those of you in the Spanish-speaking world who celebrate Christmas, enjoy our favorite holiday dish: α-jores!

Guess who snagged a sweet spot presenting on the closing day of the upcoming 43rd Annual J.P. Morgan #HealthcareConference?   Pardon us for tooting our own horn a bit, but speaking at the industry’s largest healthcare #investment symposium is quite the feather in our cap.   Want to learn about the strides we are making in our fight to beat #cancer? Come and hear the Company presentation, January 16th, 2025 9:45AM, at the Westin St. Francis, San Francisco. Webcast link: https://lnkd.in/dTX2hgc4  

Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day Alpha Tau Medical announced today that an abstract entitled “Interim analysis of feasibility, safety, and tumor control in two first-in-human trials of a novel alpha-emitting radionuclide for pancreatic adenocarcinoma,” submitted by principal investigators involved in the Company’s Israeli #pancreaticcancer trial, has been accepted to the 2025 #ASCO Gastrointestinal Cancers Symposium, to be held January 23 – 25, 2025 in San Francisco, CA. The poster will be presented during “Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract,” on January 24, 2025 at 11:30am – 1:00pm PT. To read the full announcement, please read: https://lnkd.in/d3Ut3UqN

Alpha Tau Medical announced today that following its Annual General Meeting of Company shareholders in Jerusalem, Ms. Maya Netser has been appointed to the Company’s Board of Directors (“Board”). Mr. Meir Jakobsohn is completing his term on the Board, having decided not to pursue re-election, but will continue to serve the Company in an advisory capacity. To see the full announcement, please read: https://lnkd.in/dzQkw-9b

Alpha Tau Medical announces that CEO Uzi Sofer and CFO Raphi Levy will present a #corporateoverview and update at the J.P. Morgan 43rd Annual #HealthcareConference on Thursday, January 16, 2025 at 9:45am PT / 12:45pm ET, in San Francisco, CA, and will host institutional #investor meetings at the event. https://lnkd.in/du3A8x58